David Glover
Corporate Officer/Principal at University of Cambridge
Profile
David Glover is the founder of Cyclacel Pharmaceuticals, Inc., which was founded in 1996.
He held the title of Chief Scientist at the company.
Currently, Dr. Glover is a Professor at the University of Cambridge, starting in 2013.
He is also a Member of the European Molecular Biology Organization.
In the past, he worked as a Director at Cancer Research UK, a Professor & Head-Biochemistry at Imperial College London, and a Professor-Molecular Genetics at the University Of Dundee.
David Glover active positions
Companies | Position | Start |
---|---|---|
University of Cambridge | Corporate Officer/Principal | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Former positions of David Glover
Companies | Position | End |
---|---|---|
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Director/Board Member | 20/06/2011 |
University Of Dundee | Corporate Officer/Principal | - |
Imperial College London | Corporate Officer/Principal | - |
CYCLACEL PHARMACEUTICALS, INC. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
European Molecular Biology Organization | |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- David Glover